Unknown

Dataset Information

0

Amino Acid Carbamates As Prodrugs Of Resveratrol.


ABSTRACT: Resveratrol (3, 5, 4'-trihydroxy-trans-stilbene), a plant polyphenol, has important drug-like properties, but its pharmacological exploitation in vivo is hindered by its rapid transformation via phase II conjugative metabolism. One approach to bypass this problem relies on prodrugs. We report here the synthesis, characterization, stability and in vivo pharmacokinetic behaviour of prodrugs of resveratrol in which the OH groups are engaged in an N-monosubstituted carbamate ester (-OC(O)NHR) linkage with a natural amino acid (Leu, Ile, Phe, Thr) to prevent conjugation and modulate the physicochemical properties of the molecule. We also report a convenient, high-yield protocol to obtain derivatives of this type. The new carbamate ester derivatives are stable at pH 1, while they undergo slow hydrolysis at physiological pH and hydrolyse with kinetics suitable for use in prodrugs in whole blood. After administration to rats by oral gavage the isoleucine-containing prodrug was significantly absorbed, and was present in the bloodstream as non-metabolized unaltered or partially deprotected species, demonstrating effective shielding from first-pass metabolism. We conclude that prodrugs based on the N-monosubstituted carbamate ester bond have the appropriate stability profile for the systemic delivery of phenolic compounds.

SUBMITTER: Mattarei A 

PROVIDER: S-EPMC4604475 | biostudies-other | 2015

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC6017415 | biostudies-literature
| S-EPMC7125651 | biostudies-literature
| S-EPMC2569826 | biostudies-literature
| S-EPMC5826767 | biostudies-other
| S-EPMC9906736 | biostudies-literature
| S-EPMC6942214 | biostudies-literature
| S-EPMC7871027 | biostudies-literature
| S-EPMC6580537 | biostudies-literature
| S-EPMC4014701 | biostudies-literature
| S-EPMC6332312 | biostudies-literature